Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Reinisch, Mattea; Untch, Michael; Mahlberg, Rolf et al.
Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference-Substudy of the randomised phase III GAIN-2 studyBREAST. Bd. 66. 2022 S. 110-117
Krajnak, S.; Trier, J. P.; Anic, K. et al.
Synergistic anticancer Effects of low-dose Vinorelbine in Combination with Alpelisib in Hormone Receptor-positive PIK3CA mutant Breast Carcinoma CellsGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 82. H. 10. 2022 S. E110-E110
Kiweler, Nicole; Schwarz, Helena; Nguyen, Alexandra et al.
The epigenetic modifier HDAC2 and the checkpoint kinase ATM determine the responses of microsatellite instable colorectal cancer cells to 5-fluorouracilCELL BIOLOGY AND TOXICOLOGY. 2022
Gropp-Meier, M.; Sehouli, J.; Meier, W. et al.
The Importance of CA 125 in Female Patients in DESKTOP III/ ENGOT-ov 20GEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 82. H. 10. 2022 S. E76-E76
Anic, Katharina; Altehoefer, Christin; Krajnak, Slavomir et al.
The preoperative G8 geriatric screening tool independently predicts survival in older patients with endometrial cancer: results of a retrospective single-institution cohort studyJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2022
Mikuteit, Marie; Zschabitz, Stefanie; Stoer, Christine et al.
The prognostic impact of Claudin 6 in papillary renal cell carcinomaPATHOLOGY RESEARCH AND PRACTICE. Bd. 231. 2022
Mondorf, Yvonne; Mikuteit, Marie; Ivanyi, Philipp et al.
The Prognostic Impact of PD-L2 in Papillary Renal-Cell CarcinomaUROLOGIA INTERNATIONALIS. 2022
Degirmenci, Yaman; Schepers, Markus; Steetskamp, Joscha et al.
Three-dimensional vs two-dimensional endoscopic approach in urogynecology: A retrospective cohort study of laparoscopic sacrocolpopexyJOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH. 2022
Schochter, Fabienne; Huober, Jens; Fehm, Tanja et al.
Toxicity of chemo- versus endocrine therapy in combination with dual HER2-targeted therapy with trastuzumab and pertuzumab plus ribociclib in patients with HER2 positive and hormone-receptor positive metastatic breast cancer - results from an Interim Safety Analysis of DETECT VONCOLOGY RESEARCH AND TREATMENT. Bd. 45. H. SUPPL 3. 2022 S. 26-26
Schmidt, Marcus
Vaccination strategies in breast cancerGYNAKOLOGIE. 2022